AgingResearch.NewsJoin free

Glycomacropeptide

Intervention

1 paper studies it3 findings

Across all fields, 1 paper: 1 trial in people

More peptides

C, W, M, H: cells, worms or flies, mice, humans. Dark: independent labs found the same change there. Light: one lab or one study. Outline: nothing yet.

  • 1 lab in 1 country
  • Human trial1

Outcomes

3

Streptococcus

downin humans1

1 study

  1. Glycomacropeptide decreases Streptococcus in humans (P = 0.009).

    “Ingestion of GMP supplements twice daily reduced members of the genus Streptococcus (P = 0.009) and thrice daily consumption reduced overall α diversity.”

    Human trialsupplementtwice daily1 wkfemalesn = 13

    Glycomacropeptide Impacts Amylin-Mediated Satiety, Postprandial Markers of Glucose Homeostasis, and the Fecal Microbiome in Obese Postmenopausal Women

    The Journal of nutrition

More on Streptococcus

Amylin

upin humans1

1 study

  1. Glycomacropeptide increases amylin in humans (significantly higher).

    “Postprandial AUC amylin concentration was significantly higher with GMP than that with the soy MTT and correlated with C-peptide (P < 0.001; R2 = 0.52) and greater satiety.”

    Human trialcompared with soy MTTsupplementfemalesn = 13

    Glycomacropeptide Impacts Amylin-Mediated Satiety, Postprandial Markers of Glucose Homeostasis, and the Fecal Microbiome in Obese Postmenopausal Women

    The Journal of nutrition

More on Amylin

Glucagon

downin humans1

1 study

  1. Glycomacropeptide decreases glucagon in humans (significantly lower).

    “The postprandial area under the curve (AUC) for glucagon concentrations was significantly lower, and the insulin-glucagon ratio was significantly higher with GMP than that with the soy MTT.”

    Human trialcompared with soy MTTsupplementfemalesn = 13

    Glycomacropeptide Impacts Amylin-Mediated Satiety, Postprandial Markers of Glucose Homeostasis, and the Fecal Microbiome in Obese Postmenopausal Women

    The Journal of nutrition

More on Glucagon

Latest

Related